RQ-00311610

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameRQ-00311610

Drug Alias Namecalcium channel blocker (bladder dysfunction), RaQualia Pharma

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionVoltage-gated T-type calcium channel blockers

TargetsVoltage-gated T-type calcium channel

Therapy Area/IndicationsUrinary Bladder Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesRaqualia Pharma Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsUrinary Bladder Diseases

ATC CodeN/A